Log In
Print this Print this

XOMA 129

  Manage Alerts
Collapse Summary General Information
Company Xoma Corp.
DescriptionFab against human insulin receptor
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationHypoglycemia
Indication DetailsTreat hypoglycemia
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today